Kullanım Kılavuzu
Neden sadece 3 sonuç görüntüleyebiliyorum?
Sadece üye olan kurumların ağından bağlandığınız da tüm sonuçları görüntüleyebilirsiniz. Üye olmayan kurumlar için kurum yetkililerinin başvurması durumunda 1 aylık ücretsiz deneme sürümü açmaktayız.
Benim olmayan çok sonuç geliyor?
Birçok kaynakça da atıflar "Soyad, İ" olarak gösterildiği için özellikle Soyad ve isminin baş harfi aynı olan akademisyenlerin atıfları zaman zaman karışabilmektedir. Bu sorun tüm dünyadaki atıf dizinlerinin sıkça karşılaştığı bir sorundur.
Sadece ilgili makaleme yapılan atıfları nasıl görebilirim?
Makalenizin ismini arattıktan sonra detaylar kısmına bastığınız anda seçtiğiniz makaleye yapılan atıfları görebilirsiniz.
  Atıf Sayısı 3
 Görüntüleme 15
Down Sendromu için Gebelere Yapılan Prenatal Tarama ve Tanı Testlerinin Sonuçları; Maliyet Analizi
2019
Dergi:  
Ankara Medical Journal
Yazar:  
Özet:

Objectives: Down Syndrome is the most common hereditary syndrome and presents approximately one in every 800 to 1000 live births. Because Down Syndrome is the most common non-fatal trisomy, It is on the focus of the most genetic screening and diagnostic testing protocols. The aim of our study is to evaluate the cost of prenatal screening and diagnostic tests performed in our hospital and to find out the number of live -born babies with Down syndrome. Materials and Methods: The study was conducted between May-July 2017 SBU Zekai Tahir Burak Women’s Health Education and Research Hospital. The recorts of 2300 pregnant women were screened. The cost of down syndrome screening and diagnosis was calculated. Results: Results of 1096 pregnant women with prenatal Down syndrome screening from 2300 pregnants who were followed up in antenatal outpatient clinics of our hospital were evaluated. 19(1,73%) CVS and 50(4,56%) amniocentesis were performed as an invasive procedure for the genetic diagnosis of the pregnants. According to the test results, 8(%0,72) pregnant women were diagnosed as Trisomy 21. Pregnancy outcomes were like these; pregnancy termination applicated to 4 pregnancies (1 CVS and 3 Amniocentesis cases), 2 pregnancies (post-CVS) aborted spontaneously, 1 pregnancy resulted in preterm stillbirth and one pregnant live birth. During the same time period, one pregnant with high risk screening test result didn't accept amniocentesis and had a live baby with Down Syndrome. As a result, only 2 (0,18%) infants with Down syndrome were live birth. We spent a total of 11.856,00 TL for those who had only double screening test done, 14.169,30 TL for those who had only triple screening test done, 75.738,30 TL for those had both double and triple screening tests done, 16.810,00 TL for pregnants who were genetically diagnosed by amniocentesis and 7.653,20 TL for pregnants who were genetically diagnosed by CVS method. Only eight Down Syndrome cases diagnosed by spending a total of 126.226,80 TL. Conclusion: As a result of the more effective use of prenatal tests with accurate councelling about Down Syndrome, expences on pregnants who reject pregnancy termination can be used to solve the health problems of live born children with Down Syndrome and to bring them to community by increasing their quality of life. If optimal medical and social support is provided, the life quality of individuals with Down's syndrome can be significantly improved and significant contributions can be made to the community by making special assessments and examinations.

Anahtar Kelimeler:

Results of Prenatal Screening and Diagnostic Tests for Pregnancy for Down Syndrome; Cost Analysis
2019
Yazar:  
Özet:

Objectives: Down syndrome is the most common hereditary syndrome and presents approximately one in every 800 to 1000 live births. Because Down Syndrome is the most common non-fatal trisomy, It is on the focus of the most genetic screening and diagnostic testing protocols. The aim of our study is to evaluate the cost of prenatal screening and diagnostic tests performed in our hospital and to find out the number of live-born babies with Down syndrome. Materials and Methods: The study was conducted between May-July 2017 SBU Zekai Tahir Burak Women's Health Education and Research Hospital. The records of 2300 pregnant women were screened. The cost of down syndrome screening and diagnosis was calculated. Results: Results of 1096 pregnant women with prenatal Down syndrome screening from 2300 pregnants who were followed up in antenatal outpatient clinics of our hospital were evaluated. 19(1,73%) CVS and 50(4,56%) amniocentesis were performed as an invasive procedure for the genetic diagnosis of the pregnant. According to the test results, 8(0.72) pregnant women were diagnosed as Trisomy 21. Pregnancy outcomes were like these; pregnancy termination applied to 4 pregnancies (1 CVS and 3 amniocentesis cases), 2 pregnancies (post-CVS) aborted spontaneously, 1 pregnancy resulted in premature stillbirth and one pregnant live birth. During the same time period, one pregnant with high risk screening test result didn’t accept amniocentesis and had a live baby with Down Syndrome. As a result, only 2 (0.18%) infants with Down syndrome were born alive. We spent a total of 11.856,00 PLN for those who had only double screening test done, 14.169,30 PLN for those who had only triple screening test done, 75.738,30 PLN for those who had both double and triple screening tests done, 16.810,00 PLN for pregnants who were genetically diagnosed by amniocentesis and 7.653,20 PLN for pregnants who were genetically diagnosed by CVS method. Only eight Down Syndrome cases diagnosed by spending a total of 126.226,80 TL. Conclusion: As a result of the more effective use of prenatal tests with accurate counseling about Down Syndrome, expenses on pregnant who reject pregnancy termination can be used to solve the health problems of live born children with Down Syndrome and to bring them to the community by increasing their quality of life. If optimal medical and social support is provided, the quality of life of individuals with Down’s syndrome can be significantly improved and significant contributions can be made to the community by making special assessments and examinations.

Anahtar Kelimeler:

Atıf Yapanlar
Dikkat!
Yayınların atıflarını görmek için Sobiad'a Üye Bir Üniversite Ağından erişim sağlamalısınız. Kurumuzun Sobiad'a üye olması için Kütüphane ve Dokümantasyon Daire Başkanlığı ile iletişim kurabilirsiniz.
Kampüs Dışı Erişim
Eğer Sobiad Abonesi bir kuruma bağlıysanız kurum dışı erişim için Giriş Yap Panelini kullanabilirsiniz. Kurumsal E-Mail adresiniz ile kolayca üye olup giriş yapabilirsiniz.
Benzer Makaleler










Ankara Medical Journal

Alan :   Sağlık Bilimleri

Dergi Türü :   Uluslararası

Metrikler
Makale : 689
Atıf : 1.646
2023 Impact/Etki : 0.136
Ankara Medical Journal